title: Age of onset of RNA toxicity influences phenotypic severity: evidence from an inducible mouse model of myotonic dystrophy (DM1).
abstract: Myotonic dystrophy type 1 (DM1) is the most common muscular dystrophy in adults. It is caused by an expanded (CTG)n tract in the 3' UTR of the Dystrophia Myotonica Protein Kinase (DMPK) gene. This causes nuclear retention of the mutant mRNA into ribonuclear foci and sequestration of interacting RNA-binding proteins (such as muscleblind-like 1 (MBNL1)). More severe congenital and childhood-onset forms of the disease exist but are less understood than the adult disease, due in part to the lack of adequate animal models. To address this, we utilized transgenic mice over-expressing the DMPK 3' UTR as part of an inducible RNA transcript to model early-onset myotonic dystrophy. In mice in which transgene expression was induced during embryogenesis, we found that by two weeks after birth, mice reproduced cardinal features of myotonic dystrophy, including myotonia, cardiac conduction abnormalities, muscle weakness, histopathology and mRNA splicing defects. Notably, these defects were more severe than in adult mice induced for an equivalent period of exposure to RNA toxicity. Additionally, the utility of the model was tested by over-expressing MBNL1, a key therapeutic strategy being actively pursued for treating the disease phenotypes associated with DM1. Significantly, increased MBNL1 in skeletal muscle partially corrected myotonia and splicing defects present in these mice, demonstrating the responsiveness of the model to relevant therapeutic interventions. Furthermore, these results also represent the first murine model for early-onset DM1 and provide a tool to investigate the effects of RNA toxicity at various stages of development.
authors.affiliation: Department of Pathology, University of Virginia, Charlottesville, Virginia, United States of America.
authors.forename: Jordan T
authors.initials: JT
authors.lastname: Gladman
authors.forename: Mahua
authors.initials: M
authors.lastname: Mandal
authors.forename: Varadamurthy
authors.initials: V
authors.lastname: Srinivasan
authors.forename: Mani S
authors.initials: MS
authors.lastname: Mahadevan
mesh_terms: D020413:3' Untranslated Regions; D017668:Age of Onset; D000818:Animals; D000067879:CELF1 Protein; D004268:DNA-Binding Proteins / Q000235:genetics; D004195:Disease Models, Animal; D005260:Female; D015870:Gene Expression; D008297:Male; D051379:Mice; D008822:Mice, Transgenic; D018482:Muscle, Skeletal / Q000378:metabolism / Q000473:pathology; D009223:Myotonic Dystrophy / Q000235:genetics* / Q000378:metabolism* / Q000473:pathology; D065636:Myotonin-Protein Kinase; D010641:Phenotype; D017346:Protein Serine-Threonine Kinases / Q000235:genetics*; D012326:RNA Splicing; D012333:RNA, Messenger / Q000235:genetics* / Q000378:metabolism*; D016601:RNA-Binding Proteins / Q000235:genetics
chemical_list: D020413:3' Untranslated Regions; D000067879:CELF1 Protein; C502743:CELF1 protein, mouse; C585516:DMPK protein, mouse; D004268:DNA-Binding Proteins; C479922:Mbnl1 protein, mouse; D012333:RNA, Messenger; D016601:RNA-Binding Proteins; D065636:Myotonin-Protein Kinase; D017346:Protein Serine-Threonine Kinases
references.citation: Am J Med Genet. 2000 Dec 4;96(6):888-9
references.pmid: 11121206
references.citation: Am J Hum Genet. 2004 May;74(5):793-804
references.pmid: 15065017
references.citation: Nat Genet. 1996 Jul;13(3):316-24
references.pmid: 8673131
references.citation: Nat Genet. 2006 Sep;38(9):1066-70
references.pmid: 16878132
references.citation: Methods Mol Biol. 2012;798:231-43
references.pmid: 22130840
references.citation: Nat Genet. 2008 Jan;40(1):61-8
references.pmid: 18084293
references.citation: Eur J Morphol. 2001 Jul;39(3):169-91
references.pmid: 11910536
references.citation: Hum Mol Genet. 2006 Jul 1;15(13):2087-97
references.pmid: 16717059
references.citation: Hum Mol Genet. 2012 Aug 15;21(16):3558-67
references.pmid: 22595968
references.citation: J Cell Biol. 2012 Mar 19;196(6):699-712
references.pmid: 22431750
references.citation: Proc Natl Acad Sci U S A. 2006 Aug 1;103(31):11748-53
references.pmid: 16864772
references.citation: Arch Dis Child. 1975 Jul;50(7):514-21
references.pmid: 1167063
references.citation: Lancet. 1989 Nov 25;2(8674):1269
references.pmid: 2573772
references.citation: Hum Mol Genet. 2010 Sep 15;19(18):3614-22
references.pmid: 20603324
references.citation: Hum Mol Genet. 2012 Nov 1;21(21):4645-54
references.pmid: 22846424
references.citation: Methods Mol Biol. 2008;433:115-25
references.pmid: 18679620
references.citation: Dev Med Child Neurol. 1984 Feb;26(1):62-7
references.pmid: 6230279
references.citation: Science. 2003 Dec 12;302(5652):1978-80
references.pmid: 14671308
references.citation: Proc Natl Acad Sci U S A. 2008 Dec 23;105(51):20333-8
references.pmid: 19075228
references.citation: EMBO Rep. 2011 Jul 01;12(7):735-42
references.pmid: 21637295
references.citation: Arch Dis Child. 1975 Jul;50(7):505-13
references.pmid: 1101835
references.citation: Neuromuscul Disord. 2005 Jan;15(1):5-16
references.pmid: 15639115
references.citation: Nat Struct Mol Biol. 2010 Feb;17(2):187-93
references.pmid: 20098426
references.citation: Science. 1992 Mar 6;255(5049):1253-5
references.pmid: 1546325
references.citation: Science. 1998 May 1;280(5364):737-41
references.pmid: 9563950
references.citation: Birth Defects Orig Artic Ser. 1974;10(10):120-5
references.pmid: 4462623
references.citation: Genet Couns. 2000;11(4):317-27
references.pmid: 11140408
references.citation: Curr Neurol Neurosci Rep. 2005 Feb;5(1):55-9
references.pmid: 15676109